Trilogy Stereotactic Body Radiotherapy for Pancreatic Cancer

Completed · Phase 2

Conditions studied: Pancreatic Cancer

In brief

This study will assess the efficacy of treating locally advanced pancreatic cancer using Stereotactic Body Radiotherapy (using Trilogy) and Gemcitabine

Key facts

Study ID

NCT00350142

Run by

Albert Koong

People needed

20

Starts

2006-04-01

Expected to finish

2008-10-01

Last updated by the study team

2017-02-14

Who can join

Age: 18 and older, up to 90. Sex: any. Healthy volunteers: not accepted.

You may not qualify if…

• patients who have had prior radiotherapy to upper abdomen
• patients receiving any prior pancreatic cancer therapy
• children, pregnant, and breastfeeding women, and lab personnel are excluded
• uncontrolled intercurrent illnesses
• any concurrent malignancy

Where it is running

• Stanford University School of Medicine — Stanford, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.